CYTORI LIPOPLASTY SYSTEM WITH CELASE REAGENT— 510(k) K063235

Substantially Equivalent

Cytori Therapeutics, Inc.

FDA 510(k) clearance K063235 for CYTORI LIPOPLASTY SYSTEM WITH CELASE REAGENT, Substantially Equivalent on 2007-01-24. Applicant: Cytori Therapeutics, Inc..

Clearance details

Applicant
Cytori Therapeutics, Inc.
Product code
Code QPB
Advisory panel
General, Plastic Surgery
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
San Diego, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.